Postoperative high-dose intravenous @entity68 sucrose with low dose XXXX therapy after total hip replacement.

@entity1 @entity1501 @entity417 @entity620 @entity1307 @entity2186 @entity86 @entity46674 @entity68
@entity1307 combined with parenteral @entity68 sucrose therapy is an alternative to blood transfusion in anemic @entity1 . It was shown to be effective in surgical @entity1 in several previous studies when used in conjunction with other methods. However, there are no guidelines about safety limits in dosage amounts or intervals. In this study, we report a case of significant @entity86 managed with high dose parenteral @entity46674 , low dose @entity1307 , @entity2186 , @entity620 , and @entity1501 . An 80-year-old female @entity1 presented for severe @entity417 after a total hip arthroplasty and refused an allogenic blood transfusion as treatment. The preoperative hemoglobin of 12.2 g/dL decreased to 5.3 g/dL postoperatively. She received the aforementioned combination of @entity68 sucrose, @entity1307 , and vitamins. A total of 1,500 mg of intravenous @entity68 sucrose was given postoperatively for 6 consecutive days. @entity1307 was also administered at 2,000 IU every other day for a total of 12,000 IU. The @entity1 was discharged in good condition on the twelfth postoperative day with a hemoglobin of 8.5 g/dL. Her hemoglobin was at 11.2 g/dL on the twentieth postoperative day.
